Marshall Wace, LLP Bluebird Bio, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 308,656 shares of BLUE stock, worth $98,769. This represents 0.0% of its overall portfolio holdings.

Number of Shares

308,656

Holding current value

$98,769

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.47 - $1.35 $145,068 - $416,685	308,656 New	308,656 $160,000
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $54,963 - $99,091	19,700 New	19,700 $64,000
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $2.85 Million - $5.62 Million	761,033 Added 131.26%	1,340,806 $8.49 Million
Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $1.48 Million - $2.63 Million	502,428 Added 649.59%	579,773 $2.4 Million
Q2 2021 Aug 13, 2021	SELL	$18.04 - $22.09 $2.75 Million - $3.37 Million	-152,454 Reduced 66.34%	77,345 $2.47 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $3.28 Million - $6.7 Million	197,594 Added 613.55%	229,799 $6.93 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $885,637 - $1.22 Million	32,205 New	32,205 $1.39 Million
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $174,382 - $423,291	-6,666 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$46.96 - $61.67 $761,174 - $999,609	-16,209 Reduced 70.86%	6,666 $586,000
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $1.36 Million - $2.13 Million	22,875 New	22,875 $2.1 Million
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $2.95 Million - $4.09 Million	-38,881 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$64.44 - $104.11 $2.51 Million - $4.05 Million	38,881 New	38,881 $6.12 Million
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $236,145 - $336,898	-2,232 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $104,325 - $167,818	-1,284 Reduced 36.52%	2,232 $398,000
Q3 2017 Nov 13, 2017	BUY	$57.74 - $91.42 $203,013 - $321,432	3,516	3,516 $482,000

Others Institutions Holding BLUE

# of Institutions

152

Shares Held

63.7M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$4.94 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.35 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.5 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.49 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.23 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $24.7M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account